Screening compound: PTQLWKKVFNESLI-UHFFFAOYSA-N

Screening compound: PTQLWKKVFNESLI-UHFFFAOYSA-N
Screening compound: PTQLWKKVFNESLI-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
PTQLWKKVFNESLI-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L852-0248

Molecular Formula

C20H22N6O2S (C20 H22 N6 O2 S)

Compound Name

3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-1-methyl-N-[3-(methylsulfanyl)phenyl]-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-5-carboxamide

IUPAC name

3-(3-cyclopropyl-124-oxadiazol-5-yl)-1-methyl-N-[3-(methylsulfanyl)phenyl]-1H4H5H6H7H-pyrazolo[43-c]pyridine-5-carboxamide

SMILES

Cn(c(CC1)c2CN1C(Nc1cccc(SC)c1)=O)nc2-c1nc(C2CC2)no1

InChI

InChI=1S/C20H22N6O2S/c1-25-16-8-9-26(20(27)21-13-4-3-5-14(10-13)29-2)11-15(16)17(23-25)19-22-18(24-28-19)12-6-7-12/h3-5,10,12H,6-9,11H2,1-2H3,(H,21,27)

InChI Key

PTQLWKKVFNESLI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27480454

PTQLWKKVFNESLI-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Proteases
  • GPCR
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with PTQLWKKVFNESLI-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound PTQLWKKVFNESLI-UHFFFAOYSA-N?
Check Price and Availability of PTQLWKKVFNESLI-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of PTQLWKKVFNESLI-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for PTQLWKKVFNESLI-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for PTQLWKKVFNESLI-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of PTQLWKKVFNESLI-UHFFFAOYSA-N available by request